Voltage dependent anion channels (VDACs): a brief introduction with a focus on the outer mitochondrial compartment's roles together with hexokinase-2 in the "Warburg effect" in cancer.
In recent years there has been renewed interest and focus on mitochondria of animal and human tissues. This interest commenced in the latter part of the past century and has gained momentum during the first eight years of this new millennium. The well accepted reason is that mitochondria are now recognized to represent not only "power houses", i.e., the ATP production factories of tissues essential for cell life, but in response to a variety of different "cues" may participate significantly also in cell death, both that associated with normal turnover and that associated with disease. Conversely, in cancers (particularly the advanced) their mitochondria interact with hexokinase 2 (HK-2) resulting in suppression of cell death while supporting cell growth via enhanced glycolysis, even in the presence of oxygen (Warburg effect). The identification/elucidation of proteins and mechanisms involved in deciding and/or participating in cell fate (i.e., life, death, or cancer) has focused to a large extent on the mitochondrial outer compartment, which is taken here to collectively include the outer membrane, the space between the inner and outer membranes, and contact regions between these two membranes. Among the established proteins believed to be involved in events related to cell fate are "VDACs" that form the basis of this mini-review series. This brief introductory review focuses mainly on the past discovery by the author and colleagues that VDAC located within the outer mitochondrial compartment and its binding partner HK-2 are pivotal players in the "Warburg effect" in cancer. As one case in point, when glucose is added to liver cytosol (mitochondria-free) the rate of glycolysis is very low. However, upon addition of tumor mitochondria containing VDAC bound HK-2, the low glycolytic rate is increased to a high rate near that catalyzed by the tumor cytoplasm from which the tumor mitochondria were derived.
Pedersen
Peter L
PL
Department of Biological Chemistry, Johns Hopkins University, School of Medicine, Baltimore, MD 21205-2185, USA. ppederse@jhmi.edu
D016923:Cell Death; D006019:Glycolysis; D006593:Hexokinase / Q000378:metabolism*; D006801:Humans; D051336:Mitochondrial Membranes / Q000378:metabolism*; D024101:Mitochondrial Proteins / Q000378:metabolism*; D009363:Neoplasm Proteins / Q000378:metabolism*; D009369:Neoplasms / Q000378:metabolism*; D010100:Oxygen / Q000378:metabolism; D011485:Protein Binding; D050994:Voltage-Dependent Anion Channels / Q000378:metabolism*
D024101:Mitochondrial Proteins; D009363:Neoplasm Proteins; D050994:Voltage-Dependent Anion Channels; D006593:Hexokinase; D010100:Oxygen
Neurosci Lett. 2007 Jan 16;411(3):222-7
17116366
J Biol Chem. 2002 Mar 1;277(9):7610-8
11751859
J Neurosci Res. 2007 Nov 1;85(14):3160-70
17893921
Biochemistry. 1986 Mar 11;25(5):1015-21
3008816
Cancer Res. 1988 Feb 15;48(4):913-9
3338084
Oncogene. 2006 Aug 7;25(34):4777-86
16892090
PLoS One. 2008 Mar 19;3(3):e1852
18350175
Mol Membr Biol. 2007 Mar-Apr;24(2):148-60
17453421
J Biol Chem. 2003 Feb 21;278(8):5557-63
12482755
Annu Rev Biochem. 2004;73:87-106
15189137
Science. 1956 Aug 10;124(3215):269-70
13351639
J Biol Chem. 1988 Nov 25;263(33):17422-8
3182854
FEBS Lett. 2006 Oct 2;580(22):5125-9
16979626
J Biol Chem. 2003 Apr 4;278(14):12305-9
12560333
J Biol Chem. 1967 Apr 10;242(7):1635-45
4225734
J Biol Chem. 1981 Aug 25;256(16):8699-704
7263678
Biochim Biophys Acta. 2006 Feb;1762(2):181-90
16307870
J Biol Chem. 2004 Jul 23;279(30):31761-8
15166242
J Biol Chem. 1997 Jul 25;272(30):18966-73
9228078
Neurology. 1982 Dec;32(12):1323-9
6983044
Genes Dev. 2001 Jun 1;15(11):1406-18
11390360
Biochemistry. 1980 Oct 28;19(22):4972-7
6779859
Nat Cell Biol. 2007 May;9(5):550-5
17417626
Protein J. 2005 Jan;24(1):1-8
15756812
Proc Natl Acad Sci U S A. 1977 Sep;74(9):3735-9
198801
Curr Pharm Des. 2006;12(18):2249-70
16787253